Brimonidine Tartrate eent and Insulin glargine and lixisenatide
Determining the interaction of Brimonidine Tartrate eent and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine ophthalmic
Brand name: Alphagan P, Lumify, Alphagan
Synonyms: Brimonidine ophthalmic, Brimonidine (Ophthalmic)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine Tartrate eent-Insulin glargine and lixisenatide Subcutaneous
- Brimonidine Tartrate eent-Insulin glargine, recombinant Subcutaneous
- Brimonidine Tartrate eent-Insulin glulisine
- Brimonidine Tartrate eent-Insulin Glulisine (Cartridges and Pens)
- Brimonidine Tartrate eent-Insulin Glulisine (Vials)
- Brimonidine Tartrate eent-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Brimonidine Tartrate topical
- Insulin glargine and lixisenatide-Brimonidine topical
- Insulin glargine and lixisenatide-Brimonidine Topical application
- Insulin glargine and lixisenatide-Brintellix
- Insulin glargine and lixisenatide-Brinzolamide
- Insulin glargine and lixisenatide-Brinzolamide and Brimonidine